Evidence map›Paper›PMID 25281316›Full record

ArticleNeurobiology of disease2015

Genetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndrome.

Moran Rubinstein, Ruth E Westenbroek, Frank H Yu, Christina J Jones, Todd Scheuer, William A Catterall

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Fine mapping and candidate gene analysis of a dravet syndrome modifier locus on mouse chromosome 11.Mammalian genome : official journal of the International Mammalian Genome Society · 2022
    Article
  19. HumanJournal of neurophysiology · 2022
    Article
  20. Genetic Landscape ofMolecular syndromology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Moran RubinsteinDepartment of Pharmacology, University of Washington, Seattle, WA 98195-7280, USA.
Ruth E WestenbroekDepartment of Pharmacology, University of Washington, Seattle, WA 98195-7280, USA.
Frank H YuDepartment of Pharmacology, University of Washington, Seattle, WA 98195-7280, USA.
Christina J JonesDepartment of Pharmacology, University of Washington, Seattle, WA 98195-7280, USA.
Todd ScheuerDepartment of Pharmacology, University of Washington, Seattle, WA 98195-7280, USA.
William A CatterallDepartment of Pharmacology, University of Washington, Seattle, WA 98195-7280, USA. Electronic address: wcatt@uw.edu.
University of Washington · US

Funding

Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI DOHERTY, DANIEL · 2014 to 2019
$7.9M
CELL BIOLOGY OF THE NEURONAL SODIUM CHANNELR01NS025704 · NINDS · UNIVERSITY OF WASHINGTON · PI CATTERALL, WILLIAM A · 1988 to 2018
$6.2M
NICHD NIH HHS U54 HD083091NINDS NIH HHS R01 NS025704NINDS NIH HHS R01NS25704
6 · The paper itself

Abstract

Dominant loss-of-function mutations in voltage-gated sodium channel NaV1.1 cause Dravet Syndrome, an intractable childhood-onset epilepsy. NaV1.1(+/-) Dravet Syndrome mice in C57BL/6 genetic background exhibit severe seizures, cognitive and social impairments, and premature death. Here we show that Dravet Syndrome mice in pure 129/SvJ genetic background have many fewer seizures and much less premature death than in pure C57BL/6 background. These mice also have a higher threshold for thermally induced seizures, fewer myoclonic seizures, and no cognitive impairment, similar to patients with Genetic Epilepsy with Febrile Seizures Plus. Consistent with this mild phenotype, mutation of NaV1.1 channels has much less physiological effect on neuronal excitability in 129/SvJ mice. In hippocampal slices, the excitability of CA1 Stratum Oriens interneurons is selectively impaired, while the excitability of CA1 pyramidal cells is unaffected. NaV1.1 haploinsufficiency results in increased rheobase and threshold for action potential firing and impaired ability to sustain high-frequency firing. Moreover, deletion of NaV1.1 markedly reduces the amplification and integration of synaptic events, further contributing to reduced excitability of interneurons. Excitability is less impaired in inhibitory neurons of Dravet Syndrome mice in 129/SvJ genetic background. Because specific deletion of NaV1.1 in forebrain GABAergic interneuons is sufficient to cause the symptoms of Dravet Syndrome in mice, our results support the conclusion that the milder phenotype in 129/SvJ mice is caused by lesser impairment of sodium channel function and electrical excitability in their forebrain interneurons. This mild impairment of excitability of interneurons leads to a milder disease phenotype in 129/SvJ mice, similar to Genetic Epilepsy with Febrile Seizures Plus in humans.

Indexed as

Action PotentialsAnimalsAnimals, NewbornBiophysical PhenomenaConditioning, PsychologicalDisease Models, AnimalEpilepsies, MyoclonicExcitatory Postsynaptic PotentialsFearHippocampusHyperthermia, InducedIn Vitro TechniquesLidocaineMaleMiceMice, Inbred C57BLLidocaineNAV1.1 Voltage-Gated Sodium ChannelQX-314Scn1a protein, mouseSodium Channel BlockersAction potential thresholdDravet SyndromeEpilepsyExcitatory post synaptic potential amplificationInterneuronNa(V)1.1Sodium channels

Identifiers

PMID25281316
PMCPMC4254180
OpenAlexW2052927837

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.